Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for preparing scutellarin aglycone

A technology of scutellarin and breviscapine, which is applied in the field of drug synthesis, can solve the problems of low purity of scutellarin aglycone and difficulty in industrialized production, and achieves the effects of high purity, simple method and mild reaction conditions.

Active Publication Date: 2015-09-09
KPC PHARM INC
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In order to solve the problem of low purity of scutellarin aglycone and difficulty in industrial production in the prior art, the present invention provides a new method for preparing scutellarin aglycon that is simple, high in yield, high in purity and capable of industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for preparing scutellarin aglycone
  • A method for preparing scutellarin aglycone
  • A method for preparing scutellarin aglycone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] The invention discloses a method for preparing scutellarin aglycone, and those skilled in the art can learn from the content of this article and appropriately improve the process parameters to realize it. In particular, it should be pointed out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously make changes or appropriate changes and combinations to the methods and applications described herein without departing from the content, spirit and scope of the present invention to realize and apply the present invention. Invent technology.

[0029] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention will be further described in detail below in conjunction with specifi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided is a method for preparing scutellarin aglycone. In the method, 5,6,7,4'-tetramethoxy flavone is used as raw material, and high purity scutellarin aglycone is obtained through four steps of demethylation, acylation, hydrolyzation, and refinement. The preparing method is characterized by a low synthesis cost, a short line, and a high reaction yield, and the product is easily purified, can implement industrialized production, and has a desired industrial application prospect.

Description

technical field [0001] The invention relates to the field of drug synthesis, in particular to a method for preparing scutellarin aglycon. Background technique [0002] Scutellarein, also known as scutellarein, scutellarein, scutellarein, CAS: 529-53-3, molecular formula C 15 h 10 o 6 , molecular weight: 286.24), its structural formula is as shown in formula (I): [0003] [0004] Breviscapine has a very clear curative effect on ischemic cerebrovascular disease, coronary heart disease, hypertension, cerebral hemorrhage, cerebral thrombosis, cerebral embolism multiple neuritis, chronic arachnoiditis and its sequelae. Scutellarin aglycon exerts medicinal effect. The latest pharmacological studies have shown that the active metabolites of scutellarin in vivo are scutellarin aglycone and its glucuronidation, sulfation, methylation and other conjugates. [0005] Scutellarin can be synthesized through acylation, hydroxyl protection, glycosidation, and deacylation of scutell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D311/30
CPCC07D311/30
Inventor 张伟李鹏辉杨兆祥张雄波朱海贝王珺陈锦锌
Owner KPC PHARM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com